Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study
Background Heparin‐induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery‐associated HIT occurs after immunizing preoperative exposur...
Gespeichert in:
Veröffentlicht in: | Journal of thrombosis and haemostasis 2022-11, Vol.20 (11), p.2601-2616 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2616 |
---|---|
container_issue | 11 |
container_start_page | 2601 |
container_title | Journal of thrombosis and haemostasis |
container_volume | 20 |
creator | Warkentin, Theodore E. Sheppard, Jo‐Ann I. Whitlock, Richard P. |
description | Background
Heparin‐induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery‐associated HIT occurs after immunizing preoperative exposure to heparin.
Objective
To determine the frequency and clinical picture of HIT occurring within 4 days of cardiac surgery (early presentation) versus later presentations (typical, delayed).
Methods
We identified patients with laboratory‐confirmed HIT following cardiac surgery over 30 years in a single cardiac surgery center. Three different clinical presentations of HIT were identified: typical (HIT‐related platelet count fall beginning between postoperative days [PODs] 5–10), delayed (patients with falls after POD10 or who presented following hospital discharge), and early (established before POD5, including during cardiac surgery [acute intraoperative HIT]).
Results
Of 129 patients identified with HIT complicating cardiac surgery, 100 had typical and 16 had delayed presentation of HIT; only 13 patients (10.1%) presented with early HIT, all of whom had received exposure to UFH during the 10 days before cardiac surgery. No patient was identified in whom remote preoperative UFH exposure was implicated in explaining early HIT. Notably, five patients appeared to have had acute intraoperative HIT, without immediate adverse consequences.
Conclusions
Approximately 90% of patients with HIT after cardiac surgery appear to develop this complication due to immunization triggered by cardiac surgery; however, in approximately 10% of patients, early presentation during the first four PODs (or intraoperatively) can be explained by recent immunizing exposure to heparin. |
doi_str_mv | 10.1111/jth.15826 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9805231</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2727074023</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4436-98272a8de23aa5abd10e6663bf3955b9dcf87910525d06785b7c1edbf3d76c3c3</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS1ERUthwQsgS6yQOq0dj3_ColJVFVpUic2wthz7ZuJRJg620yo7Nt33GXkSXKatYIE3tu49_u65Ogi9o-SYlnOyyd0x5aoSL9AB5UwtpGLi5dO7ZmwfvU5pQwiteUVeoX3GlagVlQfobgXbMUTT4zFCgiGb7MOQcGhxB6OJfvj1894PbrLgcO5i2DbBzjmMMHiD29D34dYPa2xNdN5YnKa4hjh_wmc4lXoP5bstWIhHOEKOIY1gs78BbEMXYsYpT25-g_Za0yd4-3gfou-fL1bnl4vrb1-uzs-uF3a5ZGJRq0pWRjmomDHcNI4SEEKwpmU1503tbKtkTQmvuCNCKt5IS8GVtpPCMssO0emOO07NFtyDsbK6HqPfmjjrYLz-tzP4Tq_Dja5VgTJaAB8eATH8mCBlvQlTHIpnXaxJIpekYkX1caeyZd8UoX2eQIl-SEyXxPSfxIr2_d-WnpVPERXByU5w63uY_0_SX1eXO-Rvka2nIA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2727074023</pqid></control><display><type>article</type><title>Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Warkentin, Theodore E. ; Sheppard, Jo‐Ann I. ; Whitlock, Richard P.</creator><creatorcontrib>Warkentin, Theodore E. ; Sheppard, Jo‐Ann I. ; Whitlock, Richard P.</creatorcontrib><description>Background
Heparin‐induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery‐associated HIT occurs after immunizing preoperative exposure to heparin.
Objective
To determine the frequency and clinical picture of HIT occurring within 4 days of cardiac surgery (early presentation) versus later presentations (typical, delayed).
Methods
We identified patients with laboratory‐confirmed HIT following cardiac surgery over 30 years in a single cardiac surgery center. Three different clinical presentations of HIT were identified: typical (HIT‐related platelet count fall beginning between postoperative days [PODs] 5–10), delayed (patients with falls after POD10 or who presented following hospital discharge), and early (established before POD5, including during cardiac surgery [acute intraoperative HIT]).
Results
Of 129 patients identified with HIT complicating cardiac surgery, 100 had typical and 16 had delayed presentation of HIT; only 13 patients (10.1%) presented with early HIT, all of whom had received exposure to UFH during the 10 days before cardiac surgery. No patient was identified in whom remote preoperative UFH exposure was implicated in explaining early HIT. Notably, five patients appeared to have had acute intraoperative HIT, without immediate adverse consequences.
Conclusions
Approximately 90% of patients with HIT after cardiac surgery appear to develop this complication due to immunization triggered by cardiac surgery; however, in approximately 10% of patients, early presentation during the first four PODs (or intraoperatively) can be explained by recent immunizing exposure to heparin.</description><identifier>ISSN: 1538-7933</identifier><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1111/jth.15826</identifier><identifier>PMID: 35869817</identifier><language>eng</language><publisher>England: Elsevier Limited</publisher><subject>Anticoagulants ; Anticoagulants - adverse effects ; Cardiac Surgical Procedures - adverse effects ; cardiopulmonary bypass ; Cohort analysis ; Heart ; Heart surgery ; Heparin ; Heparin - adverse effects ; Humans ; Immunization ; Original ; Patients ; platelet count ; PLATELETS ; Retrospective Studies ; Thrombocytopenia ; Thrombocytopenia - chemically induced ; Thrombocytopenia - complications ; Thrombocytopenia - diagnosis ; thrombosis</subject><ispartof>Journal of thrombosis and haemostasis, 2022-11, Vol.20 (11), p.2601-2616</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.</rights><rights>2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4436-98272a8de23aa5abd10e6663bf3955b9dcf87910525d06785b7c1edbf3d76c3c3</citedby><cites>FETCH-LOGICAL-c4436-98272a8de23aa5abd10e6663bf3955b9dcf87910525d06785b7c1edbf3d76c3c3</cites><orcidid>0000-0002-4402-7809 ; 0000-0002-6863-5884 ; 0000-0002-8046-7588</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35869817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Warkentin, Theodore E.</creatorcontrib><creatorcontrib>Sheppard, Jo‐Ann I.</creatorcontrib><creatorcontrib>Whitlock, Richard P.</creatorcontrib><title>Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study</title><title>Journal of thrombosis and haemostasis</title><addtitle>J Thromb Haemost</addtitle><description>Background
Heparin‐induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery‐associated HIT occurs after immunizing preoperative exposure to heparin.
Objective
To determine the frequency and clinical picture of HIT occurring within 4 days of cardiac surgery (early presentation) versus later presentations (typical, delayed).
Methods
We identified patients with laboratory‐confirmed HIT following cardiac surgery over 30 years in a single cardiac surgery center. Three different clinical presentations of HIT were identified: typical (HIT‐related platelet count fall beginning between postoperative days [PODs] 5–10), delayed (patients with falls after POD10 or who presented following hospital discharge), and early (established before POD5, including during cardiac surgery [acute intraoperative HIT]).
Results
Of 129 patients identified with HIT complicating cardiac surgery, 100 had typical and 16 had delayed presentation of HIT; only 13 patients (10.1%) presented with early HIT, all of whom had received exposure to UFH during the 10 days before cardiac surgery. No patient was identified in whom remote preoperative UFH exposure was implicated in explaining early HIT. Notably, five patients appeared to have had acute intraoperative HIT, without immediate adverse consequences.
Conclusions
Approximately 90% of patients with HIT after cardiac surgery appear to develop this complication due to immunization triggered by cardiac surgery; however, in approximately 10% of patients, early presentation during the first four PODs (or intraoperatively) can be explained by recent immunizing exposure to heparin.</description><subject>Anticoagulants</subject><subject>Anticoagulants - adverse effects</subject><subject>Cardiac Surgical Procedures - adverse effects</subject><subject>cardiopulmonary bypass</subject><subject>Cohort analysis</subject><subject>Heart</subject><subject>Heart surgery</subject><subject>Heparin</subject><subject>Heparin - adverse effects</subject><subject>Humans</subject><subject>Immunization</subject><subject>Original</subject><subject>Patients</subject><subject>platelet count</subject><subject>PLATELETS</subject><subject>Retrospective Studies</subject><subject>Thrombocytopenia</subject><subject>Thrombocytopenia - chemically induced</subject><subject>Thrombocytopenia - complications</subject><subject>Thrombocytopenia - diagnosis</subject><subject>thrombosis</subject><issn>1538-7933</issn><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAUhS1ERUthwQsgS6yQOq0dj3_ColJVFVpUic2wthz7ZuJRJg620yo7Nt33GXkSXKatYIE3tu49_u65Ogi9o-SYlnOyyd0x5aoSL9AB5UwtpGLi5dO7ZmwfvU5pQwiteUVeoX3GlagVlQfobgXbMUTT4zFCgiGb7MOQcGhxB6OJfvj1894PbrLgcO5i2DbBzjmMMHiD29D34dYPa2xNdN5YnKa4hjh_wmc4lXoP5bstWIhHOEKOIY1gs78BbEMXYsYpT25-g_Za0yd4-3gfou-fL1bnl4vrb1-uzs-uF3a5ZGJRq0pWRjmomDHcNI4SEEKwpmU1503tbKtkTQmvuCNCKt5IS8GVtpPCMssO0emOO07NFtyDsbK6HqPfmjjrYLz-tzP4Tq_Dja5VgTJaAB8eATH8mCBlvQlTHIpnXaxJIpekYkX1caeyZd8UoX2eQIl-SEyXxPSfxIr2_d-WnpVPERXByU5w63uY_0_SX1eXO-Rvka2nIA</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Warkentin, Theodore E.</creator><creator>Sheppard, Jo‐Ann I.</creator><creator>Whitlock, Richard P.</creator><general>Elsevier Limited</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4402-7809</orcidid><orcidid>https://orcid.org/0000-0002-6863-5884</orcidid><orcidid>https://orcid.org/0000-0002-8046-7588</orcidid></search><sort><creationdate>202211</creationdate><title>Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study</title><author>Warkentin, Theodore E. ; Sheppard, Jo‐Ann I. ; Whitlock, Richard P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4436-98272a8de23aa5abd10e6663bf3955b9dcf87910525d06785b7c1edbf3d76c3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticoagulants</topic><topic>Anticoagulants - adverse effects</topic><topic>Cardiac Surgical Procedures - adverse effects</topic><topic>cardiopulmonary bypass</topic><topic>Cohort analysis</topic><topic>Heart</topic><topic>Heart surgery</topic><topic>Heparin</topic><topic>Heparin - adverse effects</topic><topic>Humans</topic><topic>Immunization</topic><topic>Original</topic><topic>Patients</topic><topic>platelet count</topic><topic>PLATELETS</topic><topic>Retrospective Studies</topic><topic>Thrombocytopenia</topic><topic>Thrombocytopenia - chemically induced</topic><topic>Thrombocytopenia - complications</topic><topic>Thrombocytopenia - diagnosis</topic><topic>thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Warkentin, Theodore E.</creatorcontrib><creatorcontrib>Sheppard, Jo‐Ann I.</creatorcontrib><creatorcontrib>Whitlock, Richard P.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Warkentin, Theodore E.</au><au>Sheppard, Jo‐Ann I.</au><au>Whitlock, Richard P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study</atitle><jtitle>Journal of thrombosis and haemostasis</jtitle><addtitle>J Thromb Haemost</addtitle><date>2022-11</date><risdate>2022</risdate><volume>20</volume><issue>11</issue><spage>2601</spage><epage>2616</epage><pages>2601-2616</pages><issn>1538-7933</issn><issn>1538-7836</issn><eissn>1538-7836</eissn><abstract>Background
Heparin‐induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery‐associated HIT occurs after immunizing preoperative exposure to heparin.
Objective
To determine the frequency and clinical picture of HIT occurring within 4 days of cardiac surgery (early presentation) versus later presentations (typical, delayed).
Methods
We identified patients with laboratory‐confirmed HIT following cardiac surgery over 30 years in a single cardiac surgery center. Three different clinical presentations of HIT were identified: typical (HIT‐related platelet count fall beginning between postoperative days [PODs] 5–10), delayed (patients with falls after POD10 or who presented following hospital discharge), and early (established before POD5, including during cardiac surgery [acute intraoperative HIT]).
Results
Of 129 patients identified with HIT complicating cardiac surgery, 100 had typical and 16 had delayed presentation of HIT; only 13 patients (10.1%) presented with early HIT, all of whom had received exposure to UFH during the 10 days before cardiac surgery. No patient was identified in whom remote preoperative UFH exposure was implicated in explaining early HIT. Notably, five patients appeared to have had acute intraoperative HIT, without immediate adverse consequences.
Conclusions
Approximately 90% of patients with HIT after cardiac surgery appear to develop this complication due to immunization triggered by cardiac surgery; however, in approximately 10% of patients, early presentation during the first four PODs (or intraoperatively) can be explained by recent immunizing exposure to heparin.</abstract><cop>England</cop><pub>Elsevier Limited</pub><pmid>35869817</pmid><doi>10.1111/jth.15826</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0002-4402-7809</orcidid><orcidid>https://orcid.org/0000-0002-6863-5884</orcidid><orcidid>https://orcid.org/0000-0002-8046-7588</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1538-7933 |
ispartof | Journal of thrombosis and haemostasis, 2022-11, Vol.20 (11), p.2601-2616 |
issn | 1538-7933 1538-7836 1538-7836 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9805231 |
source | MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library |
subjects | Anticoagulants Anticoagulants - adverse effects Cardiac Surgical Procedures - adverse effects cardiopulmonary bypass Cohort analysis Heart Heart surgery Heparin Heparin - adverse effects Humans Immunization Original Patients platelet count PLATELETS Retrospective Studies Thrombocytopenia Thrombocytopenia - chemically induced Thrombocytopenia - complications Thrombocytopenia - diagnosis thrombosis |
title | Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T21%3A08%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Temporal%20presentations%20of%20heparin%E2%80%90induced%20thrombocytopenia%20following%20cardiac%20surgery:%20A%20single%E2%80%90center,%20retrospective%20cohort%20study&rft.jtitle=Journal%20of%20thrombosis%20and%20haemostasis&rft.au=Warkentin,%20Theodore%20E.&rft.date=2022-11&rft.volume=20&rft.issue=11&rft.spage=2601&rft.epage=2616&rft.pages=2601-2616&rft.issn=1538-7933&rft.eissn=1538-7836&rft_id=info:doi/10.1111/jth.15826&rft_dat=%3Cproquest_pubme%3E2727074023%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2727074023&rft_id=info:pmid/35869817&rfr_iscdi=true |